Rani Therapeutics (RANI) Earnings Date, Estimates & Call Transcripts $2.36 -0.11 (-4.45%) (As of 11:58 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Rani Therapeutics Latest Earnings SummaryLatest Earnings DateAug. 6EstimatedActual EPS (Aug. 6) -$0.26 Beat By $0.03 Consensus EPS (Aug. 6) -$0.29 Rani Therapeutics announced Q2 2024 earnings on August 6, 2024, reporting an EPS of -$0.26, which beat the consensus estimate of -$0.29 by $0.03. With a trailing EPS of -$1.18, Rani Therapeutics' earnings are expected to grow next year, from ($0.98) to ($0.72) per share. Get Rani Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rani Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRANI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RANI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Rani Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.78-$0.78-$0.78Q2 20241-$0.71-$0.71-$0.71Q3 20241-$0.67-$0.67-$0.67Q4 20241-$0.69-$0.69-$0.69FY 20244($2.85)($2.85)($2.85) Rani Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/6/2024--$0.29-$0.26+$0.03-$0.26--5/6/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29-- 3/20/2024Q4 2023-$0.31-$0.27+$0.04-$0.27-- 11/8/2023Q3 2023-$0.47-$0.36+$0.11-$0.36-- 8/11/2023Q2 2023-$0.40-$0.37+$0.03-$0.37-- 5/10/2023Q1 2023-$0.47-$0.33+$0.14-$0.33-- Get the Latest News and Ratings for RANI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/22/2023Q4 2022-$0.34-$0.35 -$0.01-$0.35$0.65M- Rani Therapeutics Earnings - Frequently Asked Questions When did Rani Therapeutics announce their last quarterly earnings? Rani Therapeutics (NASDAQ:RANI) last announced its quarterly earning data on Tuesday, August 6, 2024. Learn more on RANI's earnings history. Did Rani Therapeutics beat their earnings estimates last quarter? In the previous quarter, Rani Therapeutics (NASDAQ:RANI) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.03. Learn more on analysts' earnings estimate vs. RANI's actual earnings. How much revenue does Rani Therapeutics generate each year? Rani Therapeutics (NASDAQ:RANI) has a recorded annual revenue of $2.72 million. How much profit does Rani Therapeutics generate each year? Rani Therapeutics (NASDAQ:RANI) has a recorded net income of -$33.97 million. RANI has generated -$1.18 earnings per share over the last four quarters. What is Rani Therapeutics's EPS forecast for next year? Rani Therapeutics's earnings are expected to grow from ($0.98) per share to ($0.72) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies PASG Earnings Results PYXS Earnings Results CRVS Earnings Results ALEC Earnings Results VERV Earnings Results ALMS Earnings Results ARCT Earnings Results AURA Earnings Results QTTB Earnings Results RGNX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! This page (NASDAQ:RANI) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
